BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 37099292)

  • 1. Intracranial and Extracranial Progression and Their Correlation With Overall Survival After Stereotactic Radiosurgery in a Multi-institutional Cohort With Brain Metastases.
    Carpenter DJ; Leng J; Arshad M; Giles W; Kirkpatrick JP; Floyd SR; Chmura SJ; Salama JK; Hong JC
    JAMA Netw Open; 2023 Apr; 6(4):e2310117. PubMed ID: 37099292
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Potential role for LINAC-based stereotactic radiosurgery for the treatment of 5 or more radioresistant melanoma brain metastases.
    Frakes JM; Figura NB; Ahmed KA; Juan TH; Patel N; Latifi K; Sarangkasiri S; Strom TJ; Chinnaiyan P; Rao NG; Etame AB
    J Neurosurg; 2015 Nov; 123(5):1261-7. PubMed ID: 26140482
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stereotactic radiosurgery combined with nivolumab or Ipilimumab for patients with melanoma brain metastases: evaluation of brain control and toxicity.
    Minniti G; Anzellini D; Reverberi C; Cappellini GCA; Marchetti L; Bianciardi F; Bozzao A; Osti M; Gentile PC; Esposito V
    J Immunother Cancer; 2019 Apr; 7(1):102. PubMed ID: 30975225
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stereotactic radiosurgery for intracranial hemangiopericytomas: a multicenter study.
    Cohen-Inbar O; Lee CC; Mousavi SH; Kano H; Mathieu D; Meola A; Nakaji P; Honea N; Johnson M; Abbassy M; Mohammadi AM; Silva D; Yang HC; Grills I; Kondziolka D; Barnett GH; Lunsford LD; Sheehan J
    J Neurosurg; 2017 Mar; 126(3):744-754. PubMed ID: 27104850
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of First-line Radiosurgery vs Whole-Brain Radiotherapy for Small Cell Lung Cancer Brain Metastases: The FIRE-SCLC Cohort Study.
    Rusthoven CG; Yamamoto M; Bernhardt D; Smith DE; Gao D; Serizawa T; Yomo S; Aiyama H; Higuchi Y; Shuto T; Akabane A; Sato Y; Niranjan A; Faramand AM; Lunsford LD; McInerney J; Tuanquin LC; Zacharia BE; Chiang V; Singh C; Yu JB; Braunstein S; Mathieu D; Touchette CJ; Lee CC; Yang HC; Aizer AA; Cagney DN; Chan MD; Kondziolka D; Bernstein K; Silverman JS; Grills IS; Siddiqui ZA; Yuan JC; Sheehan JP; Cordeiro D; Nosaki K; Seto T; Deibert CP; Verma V; Day S; Halasz LM; Warnick RE; Trifiletti DM; Palmer JD; Attia A; Li B; Cifarelli CP; Brown PD; Vargo JA; Combs SE; Kessel KA; Rieken S; Patel S; Guckenberger M; Andratschke N; Kavanagh BD; Robin TP
    JAMA Oncol; 2020 Jul; 6(7):1028-1037. PubMed ID: 32496550
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Survival after surgery and stereotactic radiosurgery for patients with multiple intracranial metastases: results of a single-center retrospective study.
    Smith TR; Lall RR; Lall RR; Abecassis IJ; Arnaout OM; Marymont MH; Swanson KR; Chandler JP
    J Neurosurg; 2014 Oct; 121(4):839-45. PubMed ID: 24857242
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of Definitive Stereotactic Body Radiotherapy and Outcomes in Adults With Extracranial Oligometastasis.
    Poon I; Erler D; Dagan R; Redmond KJ; Foote M; Badellino S; Biswas T; Louie AV; Lee Y; Atenafu EG; Ricardi U; Sahgal A
    JAMA Netw Open; 2020 Nov; 3(11):e2026312. PubMed ID: 33196810
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel risk scores for survival and intracranial failure in patients treated with radiosurgery alone to melanoma brain metastases.
    Chowdhury IH; Ojerholm E; McMillan MT; Miller D; Kolker JD; Kurtz G; Dorsey JF; Nagda SN; Geiger GA; Brem S; O'Rourke DM; Zager EL; Gangadhar T; Schuchter L; Lee JY; Alonso-Basanta M
    Radiat Oncol; 2015 Dec; 10():248. PubMed ID: 26626714
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stereotactic Radiosurgery for Women Older than 65 with Breast Cancer Brain Metastases.
    Upadhyay R; Klamer BG; Perlow HK; White JR; Bazan JG; Jhawar SR; Blakaj DM; Grecula JC; Arnett A; Mestres-Villanueva MA; Healy EH; Thomas EM; Chakravarti A; Raval RR; Lustberg M; Williams NO; Palmer JD; Beyer SJ
    Cancers (Basel); 2023 Dec; 16(1):. PubMed ID: 38201564
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stereotactic radiosurgery in the management of non-small cell lung cancer brain metastases: a prospective study using the NeuroPoint Alliance Stereotactic Radiosurgery Registry.
    Michalopoulos GD; Katsos K; Grills IS; Warnick RE; McInerney J; Attia A; Timmerman R; Chang E; Andrews DW; D'Ambrosio AL; Cobb WS; Pouratian N; Spalding AC; Walter K; Jensen RL; Bydon M; Asher AL; Sheehan JP
    J Neurosurg; 2024 May; 140(5):1223-1232. PubMed ID: 37948684
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Salvage radiosurgery for brain metastases: prognostic factors to consider in patient selection.
    Kurtz G; Zadeh G; Gingras-Hill G; Millar BA; Laperriere NJ; Bernstein M; Jiang H; Ménard C; Chung C
    Int J Radiat Oncol Biol Phys; 2014 Jan; 88(1):137-42. PubMed ID: 24331660
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treating brain metastases in metastatic breast cancer: outcomes after stereotactic radiosurgery examined in a retrospective, single-center cohort analysis.
    Depner JF; Berg T; Ejlertsen B; Andreasen LW; Møller S; Maraldo MV
    Acta Oncol; 2023 Nov; 62(11):1502-1510. PubMed ID: 37750329
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The RSSearch™ Registry: patterns of care and outcomes research on patients treated with stereotactic radiosurgery and stereotactic body radiotherapy.
    Davis JN; Medbery C; Sharma S; Danish A; Mahadevan A
    Radiat Oncol; 2013 Nov; 8():275. PubMed ID: 24274599
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Management of Brain Metastases in Tyrosine Kinase Inhibitor-Naïve Epidermal Growth Factor Receptor-Mutant Non-Small-Cell Lung Cancer: A Retrospective Multi-Institutional Analysis.
    Magnuson WJ; Lester-Coll NH; Wu AJ; Yang TJ; Lockney NA; Gerber NK; Beal K; Amini A; Patil T; Kavanagh BD; Camidge DR; Braunstein SE; Boreta LC; Balasubramanian SK; Ahluwalia MS; Rana NG; Attia A; Gettinger SN; Contessa JN; Yu JB; Chiang VL
    J Clin Oncol; 2017 Apr; 35(10):1070-1077. PubMed ID: 28113019
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treating Brain Metastases from Breast Cancer: Outcomes after Stereotactic Radiosurgery.
    Wilson TG; Robinson T; MacFarlane C; Spencer T; Herbert C; Wade L; Reed H; Braybrooke JP
    Clin Oncol (R Coll Radiol); 2020 Jun; 32(6):390-396. PubMed ID: 32131980
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Salvage stereotactic radiosurgery for breast cancer brain metastases: outcomes and prognostic factors.
    Kelly PJ; Lin NU; Claus EB; Quant EC; Weiss SE; Alexander BM
    Cancer; 2012 Apr; 118(8):2014-20. PubMed ID: 21918959
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of 2-staged stereotactic radiosurgery for treatment of brain metastases ≥ 2 cm.
    Angelov L; Mohammadi AM; Bennett EE; Abbassy M; Elson P; Chao ST; Montgomery JS; Habboub G; Vogelbaum MA; Suh JH; Murphy ES; Ahluwalia MS; Nagel SJ; Barnett GH
    J Neurosurg; 2018 Aug; 129(2):366-382. PubMed ID: 28937324
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk Factors for Progression and Toxic Effects After Preoperative Stereotactic Radiosurgery for Patients With Resected Brain Metastases.
    Prabhu RS; Akinyelu T; Vaslow ZK; Matsui JK; Haghighi N; Dan T; Mishra MV; Murphy ES; Boyles S; Perlow HK; Palmer JD; Udovicich C; Patel TR; Wardak Z; Woodworth GF; Ksendzovsky A; Yang K; Chao ST; Asher AL; Burri SH
    JAMA Oncol; 2023 Aug; 9(8):1066-1073. PubMed ID: 37289451
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Imaging-defined necrosis after treatment with single-fraction stereotactic radiosurgery and immune checkpoint inhibitors and its potential association with improved outcomes in patients with brain metastases: an international multicenter study of 697 patients.
    Lehrer EJ; Ahluwalia MS; Gurewitz J; Bernstein K; Kondziolka D; Niranjan A; Wei Z; Lunsford LD; Fakhoury KR; Rusthoven CG; Mathieu D; Trudel C; Malouff TD; Ruiz-Garcia H; Bonney P; Hwang L; Yu C; Zada G; Patel S; Deibert CP; Picozzi P; Franzini A; Attuati L; Prasad RN; Raval RR; Palmer JD; Lee CC; Yang HC; Jones BM; Green S; Sheehan JP; Trifiletti DM
    J Neurosurg; 2023 May; 138(5):1178-1187. PubMed ID: 36115055
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Determinants of Symptomatic Intracranial Progression After an Initial Stereotactic Radiosurgery Course.
    Leng JX; Carpenter DJ; Huang C; Qazi J; Arshad M; Mullikin TC; Reitman ZJ; Kirkpatrick JP; Floyd SR; Fecci PE; Chmura SJ; Hong JC; Salama JK
    Adv Radiat Oncol; 2024 Jun; 9(6):101475. PubMed ID: 38690297
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.